You are in:Home/Publications/Decrease of serum biomarker of type II Collagen degradation (Coll2-1) by intra-articular injection of an autologous plasma-rich-platelet in patients with unilateral primary knee osteoarthritis | |
Dr. Rasha Mohamed Fawzy Mohamed Abd Eaziz :: Publications: |
Title: | Decrease of serum biomarker of type II Collagen
degradation (Coll2-1) by intra-articular injection of
an autologous plasma-rich-platelet in patients with
unilateral primary knee osteoarthritis |
Authors: | Rasha Mohamed Fawzy1, Nashwa Ismail Hashaad1, Amira Ibrahim Mansour2 |
Year: | 2017 |
Keywords: | Platelet-rich plasma, growth factors, serum coll2-1, knee osteoarthritis, Western Ontario, McMaster Universities Arthritis Index Score |
Journal: | Not Available |
Volume: | Not Available |
Issue: | Not Available |
Pages: | Not Available |
Publisher: | Not Available |
Local/International: | International |
Paper Link: | Not Available |
Full paper | Rasha Mohamed Fawzy Mohamed Abd Eaziz_serum coll-2.pdf |
Supplementary materials | Not Available |
Abstract: |
Objective: This study aimed to evaluate the effect of one dose of intra-articular injection of (PRP) in the knee joint on a specific osteoarthritis (OA) serum biomarker of cartilage degeneration, Collagen 2-1 (Coll2-1), over a short period of 3 months. The aim extended to clarify the effect of PRP on the functional status of the osteoarthritic knee joint. Material and Methods: Sixty patients with primary unilateral knee OA were enrolled in this study. They were subdivided according to Kellgren-Lawrence grading scale (KL) into (Group Ι): including patients with KL grade < 3 and (Group ΙΙ): including patients with KL grade ≥3. Patients were asked to complete the Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score. PRP was prepared and injected immediately into the affected knee. Serum Coll2-1 (S.Coll2-1) concentration was measured by enzyme-linked immunosorbent assay (ELISA) kit pre and 3 months after PRP injection. Results: Significant reduction in S.Coll2-1 concentration in primary knee OA patients; (p |